Online Measurement of Cognitive functioning in patients with cancers with CNS involvement

• Conditions: Cognitive deficits; memory and concentration problems; 10027476; 10042258

• Registration Number: NL-OMON51344
• Lead Sponsor: Antoni van Leeuwenhoek Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Patients diagnosed with >= 1 brain metastases
Scheduled for, or treated with stereotactic radiotherapy
Age range 18-89

Exclusion Criteria

Insufficient command of the Dutch language

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>We will calculate completion rates for the classical neuropsychological test<br /><br>outcomes and for the ACS test outcomes. The completion rate for each test<br /><br>outcome of the ACS, is considered acceptable when at most 10% lower than the<br /><br>completion rate of the equivalent classical neuropsychological test.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n.a.</p><br>